PT Ikapharmindo Putramas Tbk (IDX:IKPM)
Indonesia · Delayed Price · Currency is IDR 254.00
-8.00 (-3.05%)
At close: Feb 9, 2026
IDX:IKPM Revenue
PT Ikapharmindo Putramas Tbk had revenue of 81.65B IDR in the quarter ending September 30, 2025, a decrease of -13.75%. This brings the company's revenue in the last twelve months to 379.27B, down -10.74% year-over-year. In the year 2024, PT Ikapharmindo Putramas Tbk had annual revenue of 412.07B, down -6.59%.
Revenue (ttm)
379.27B
Revenue Growth
-10.74%
P/S Ratio
1.13
Revenue / Employee
398.39M
Employees
952
Market Cap
427.90B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 412.07B | -29.07B | -6.59% |
| Dec 31, 2023 | 441.14B | 42.40B | 10.63% |
| Dec 31, 2022 | 398.73B | 17.82B | 4.68% |
| Dec 31, 2021 | 380.92B | -334.88B | -46.78% |
| Dec 31, 2020 | 715.80B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.51T |
| PT Sejahteraraya Anugrahjaya Tbk | 3.30T |
| PT Itama Ranoraya Tbk | 1.41T |
| PT Royal Prima Tbk | 332.14B |
| PT Indofarma Tbk | 206.24B |
| PT UBC Medical Indonesia Tbk | 176.64B |